(Q35250764)

7 August 2017

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients (English)

1 reference

7 August 2017

1 reference

Maria Fara De Caro

7

0 references

Francesco Girolamo

Francesco Girolamo

9

0 references

Carla Tortorella

Carla Tortorella

3

0 references

Isabella Laura Simone

Isabella Laura Simone

1

0 references

Paolo Livrea

Paolo Livrea

10

0 references

author name string

Antonia Ceccarelli

2

1 reference

7 August 2017

Alessandra Bellacosa

4

1 reference

7 August 2017

Fabio Pellegrini

5

1 reference

7 August 2017

Immacolata Plasmati

6

1 reference

7 August 2017

Mariangela Lopez

8

1 reference

7 August 2017

12 December 2006

1 reference

Health and Quality of Life Outcomes

7 August 2017

1 reference

7 August 2017

4

1 reference

7 August 2017

96

1 reference

Creative Commons Attribution 2.0 Generic

7 August 2017

start time

1 December 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1477-7525-4-96

0 references

cites work

Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life and impairment in patients with multiple sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

A comparison of health utility measures for the evaluation of multiple sclerosis treatments

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

An Inventory for Measuring Depression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

The use of quality of life measures in multiple sclerosis research.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Validation of Italian multiple sclerosis quality of life 54 questionnaire

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

The MOS 36-ltem Short-Form Health Survey (SF-36)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life during the first 6 months of interferon-beta treatment in patients with MS.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Treatment with interferon beta-1b improves quality of life in multiple sclerosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1716163

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17163989

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17163989

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Burden of illness of multiple sclerosis: Part II: Quality of life. The Canadian Burden of Illness Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17163989

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1477-7525-4-96

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference

7 August 2017

1 reference